⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VERA News
Vera Therapeutics, Inc. Class A Common Stock
Form 8-K
sec.gov
VERA
Vera Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results
globenewswire.com
VERA
Vera Therapeutics to Participate at Upcoming Investor Conferences
globenewswire.com
VERA
$555+ Mn AI in Patient Scheduling Software Market Forecast to 2033 Featuring Veradigm, Epic Systems, Hyro, Assort Health, Notable, Voiceoc, Zocdoc, Relatient, and UnityAI
globenewswire.com
INNV
VERA
Cobalt Appoints Paul Zymba and Deepak Dalvi to Strengthen Product Innovation and Customer Success
businesswire.com
VERA
LWAC
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VERA
Global Medical Coding Market Set to Reach USD 14.01 Billion by 2030 | MarketsandMarkets™
globenewswire.com
ORCL
ACGL
VERA
CTSH
QGEN
Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer
globenewswire.com
VERA
Alamar Biosciences uzatvára nadupísané financovanie formou konvertibilných dlhopisov a rozširuje vedenie spoločnosti USA - slovenčina USA - English APAC - English USA - English USA - Français USA - Deutsch USA - Polski Korea - 한국어 USA - čeština USA -
prnewswire.com
ILMN
VERA
PFE
Компания Alamar Biosciences объявляет о закрытии финансирования за счет конвертируемых облигаций с превышением лимита подписки и о расширении руководящей команды USA - Pусский Korea - 한국어 USA - English APAC - English USA - English USA - Français USA -
prnewswire.com
ILMN
VERA
OM
MYGN
RVT
CSGP
BIIB
AMGN
PFE
TROW